151
|
Mizutani M, Okuda Y, Yamaoka T, Tsukahara K, Isaka M, Bannai C, Yamashita K. High glucose and hyperosmolarity increase platelet-derived growth factor mRNA levels in cultured human vascular endothelial cells. Biochem Biophys Res Commun 1992; 187:664-9. [PMID: 1530624 DOI: 10.1016/0006-291x(92)91246-m] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
We investigated the effects of high glucose and hyperosmolality on platelet-derived growth factor (PDGF) production and PDGF-B chain mRNA levels in cultured human umbilical vein endothelial cells. Under an excess of ambient glucose (13.8 and 27.5mM) and a hyperosmolar condition (22.0mOsm/L with mannitol), PDGF concentrations in the culture medium were both significantly increased (10.3 +/- 6.0%, 36.2 +/- 7.2%, 48.5 +/- 9.0% increase respectively compared with 5.5mM glucose). Parallel to protein secretion levels, PDGF-B chain mRNA levels showed a significant increase (57.7%, 103.7%, 210.8% increase), while no change of beta-actin mRNA levels was observed. Thus, elevated PDGF released from endothelium by high glucose may play an important role in the pathogenesis of diabetic angiopathy.
Collapse
|
152
|
Kawakami Y, Yamaoka T, Hirochika R, Yamashita K, Itakura M, Nakauchi H. Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells. Diabetes 1992; 41:956-61. [PMID: 1628770 DOI: 10.2337/diab.41.8.956] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
To develop somatic gene therapy for diabetes, we studied an animal model with proinsulin-producing fibroblasts with an immunological safety system. Cultured mouse fibroblasts of the Ltk- cell line were transfected first with the efficient human proinsulin expression vector pBMG-Neo-Ins. Initially, 2 x 10(6) cells with a proinsulin-production rate of 91 ng.24 h-1.10(6) cells-1 were transplanted i.p. into streptozocin-induced diabetic C3H mice. The blood glucose concentrations improved between the first and the 28th day, but the animals died of hypoglycemia between the 29th and 46th days. The proinsulin-producing Ltk- cells were further transfected with a second plasmid, pHEBo-CD8.2, encoding BALB/c mouse T-cell differentiation antigen. The CD8.2 allotype is different from CD8.1 allotype by only one amino acid substitution and should be only slightly antigenic to the recipient C3H mice. Somatic gene therapy with these doubly transfected cells followed by the consecutive administration of a monoclonal antibody to CD8.2 resulted in an initial decrease of blood glucose concentrations followed by the permanent recurrence of hyperglycemia, thus proving the complete removal of the transplanted cells. Cultured fibroblasts were thus proven capable of supplying sufficient proinsulin to lower the blood glucose concentrations in diabetic animals. The immunological safety system with a combination of artificial expression of cell surface antigen and the administration of the specific monoclonal antibody was an effective safety system for somatic gene therapy.
Collapse
|
153
|
Yamaoka T, Kudo T, Takuwa Y, Kawakami Y, Itakura M, Yamashita K. Hereditary adrenocortical unresponsiveness to adrenocorticotropin with a postreceptor defect. J Clin Endocrinol Metab 1992; 75:270-4. [PMID: 1320052 DOI: 10.1210/jcem.75.1.1320052] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
We report two cases in one pedigree with hereditary adrenocortical unresponsiveness to ACTH (HACUA) where it is suggested that the pathogenic defect occurs after cAMP generation. Although the patients showed increased plasma ACTH, decreased plasma cortisol and dehydroepiandrosterone, and no steroidogenic response to exogenous ACTH, they responded normally to both furosemide administration and to a low sodium diet by showing increases in plasma aldosterone. The peripheral blood mononuclear leukocytes (MNLs) from these patients possessed ACTH receptors similar to adrenocortical ones, which was in contrast to a previously reported case with a deficiency of ACTH receptors in the MNLs. Furthermore, ACTH receptors in the patients' MNLs were functionally coupled to adenylate cyclase. Dibutyryl cAMP infusion did not, however, increase plasma cortisol nor aldosterone in these patients in a sharp contrast to its remarkable increase in a normal control subject. These results suggest that these patients represent a new subtype of HACUA with a failure of intracellular reception of the cAMP message in adrenocortical cells. We propose to classify our patients with a postreceptor defect as HACUA type II using an analogy to pseudohypoparathyroidism type II.
Collapse
|
154
|
Yamaoka T, Matsuura Y, Yamashita K, Tanimoto T, Nishimura C. Site-directed mutagenesis of His-42, His-188 and Lys-263 of human aldose reductase. Biochem Biophys Res Commun 1992; 183:327-33. [PMID: 1543503 DOI: 10.1016/0006-291x(92)91647-9] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The role of His42, His188, and Lys263 residues in the catalytic action of human aldose reductase was investigated in association with various inhibitors of this enzyme by site-directed mutagenesis. While mutations at His42- greater than Gln, His42- greater than Tyr, His188- greater than Gln, and His188- greater than Tyr brought small change in the kinetic parameters, Lys263- greater than Glu mutation markedly increased the Km value for the substrate DL-glyceraldehyde by a factor of 60. Lys263- greater than Met substitution resulted in approximately 14 fold elevation of Km for the substrate. By contrast, mutation of Lys263- greater than Arg significantly decreased the Km for the substrate with concomitant reduction in kcat. Moderate increase in Km values for the cofactor NADPH was demonstrated for mutated enzymes. These results are indicative of the possible role of Lys263 in the substrate binding through electrostatic interaction. The inhibitor constants (Ki) for structurally diverse aldose reductase inhibitors against mutated enzymes demonstrated different degree of alteration, indicating binding sites of aldose reductase inhibitors on the enzyme molecule vary from one another, and some of the sites are more closely correlated with the physicochemical property of Lys263.
Collapse
|
155
|
Tabata Y, Uno K, Yamaoka T, Ikada Y, Muramatsu S. Effects of recombinant alpha-interferon-gelatin conjugate on in vivo murine tumor cell growth. Cancer Res 1991; 51:5532-8. [PMID: 1833052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
A recombinant human alpha-interferon A/D (IFN), also known to be effective in mice, was conjugated to gelatin with a water-soluble carbodiimide. The IFN-gelatin conjugate was much more efficient than free IFN in activating mouse peritoneal macrophages (Mø) in an in vitro experiment to inhibit the growth of IFN-resistant subline cells (RR1) of murine fibrosarcoma. A single i.p. injection of the conjugate administered to normal mice was also more effective than one of free IFN in activating peritoneal Mø and natural killer cells in peritoneal exudate cell and spleen cell populations. In the investigation on body distribution of the IFN-gelatin conjugate, an enhanced affinity to Mø as well as a prolonged retention were observed in comparison with free IFN. An injection of the IFN-gelatin conjugate i.p. was more effective than one of free IFN in suppressing the in vivo growth of not only IFN-sensitive SS2 cells but also RR1 cells in the peritoneal cavity of mice, although RR1 cells were only susceptible to the indirect effect of IFN via host cells, in contrast to SS2 cells. In addition to an increased recruitment of Mø to the peritoneal cavity in RR1-bearing mice receiving i.p. injection of the IFN-gelatin conjugate, these Mø were activated to inhibit the in vitro growth of RR1 cells. These results indicate that the IFN-gelatin conjugate is a promising antitumor agent that is much more effective than free IFN. The dose of IFN in the conjugate required for exerting the antitumor effects is much lower than that of free IFN, which leads to a reduction of adverse effects of IFN.
Collapse
|
156
|
Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. BIOCHIMICA ET BIOPHYSICA ACTA 1991; 1078:171-8. [PMID: 1905957 DOI: 10.1016/0167-4838(91)99006-e] [Citation(s) in RCA: 73] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Large quantities of recombinant human aldose reductase were produced using Spodoptera frugiperda cells and properties of the enzyme were characterized. Direct purification of the recombinant aldose reductase by affinity column chromatography using Matrex gel orange A yielded a single 36 kDa band, similar in size to the purified human muscle aldose reductase, on a sodium dodecyl sulfate-polyacrylamide gel after silver staining. The isoelectric point of the recombinant enzyme was 5.85 which is identical to the human muscle aldose reductase. Following the treatment with an acylamino-acid releasing enzyme, the blocked NH2-terminal amino acid was identified to be acetylalanine. The successive NH2-terminal sequence and that of the COOH-terminal peptide concurred with the expected translated sequence. Kinetic analyses of the recombinant enzyme activity for various substrates and the cofactor, NADPH, demonstrated a good agreement with the previously reported kinetic data on the purified human aldose reductase. A high concentration of (NH4)2SO4 elicited a significant increase in both Km and Kcat for DL-glyceraldehyde as well as D-glucose. Although IC50 values for most of the aldose reductase inhibitors with recombinant enzyme were found to fall within the comparable range of those obtained with nonhuman mammalian enzymes, the IC50 value for epalrestat was more than 10-fold higher in the recombinant enzyme. These results indicate that the recombinant human aldose reductase expressed in the baculovirus system possesses structurally and enzymatically similar properties as those reported for the native human enzyme and should serve as a superior enzyme preparation to nonhuman mammalian enzymes for the screening of the efficacy and potency of newly developed aldose reductase inhibitors.
Collapse
|
157
|
Itakura M, Yoshikawa H, Bannai C, Kato M, Kunika K, Kawakami Y, Yamaoka T, Yamashita K. Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats. Life Sci 1991; 49:889-97. [PMID: 1875797 DOI: 10.1016/0024-3205(91)90174-a] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The effect of aminoguanidine (AG) on diabetic proteinuria was studied in control rats ([C]), streptozotocin (SZ)-induced diabetic rats ([DM]), control rats treated with AG [( C + AG]), or diabetic rats treated with AG [( DM + AG]). Increased glycation of hemoglobin (HbA1C), and glomerular basement membrane (GBM) type IV collagen (IV-C) at 10 wk of stable diabetes were associated with the appearance of high-molecular-weight (HMW) cross-linked type I collagen and HMW proteinuria of 62 kD, 69 kD albumin and 77 kD proteins to the levels of 362, 381, and 408%, while 9.9, 13.5, 17, 18, and 23 kD proteins were decreased, respectively, to non-detectable, 37, 16, and 13%. AG decreased cross-linkage of type I collagen and significantly decreased urinary 62 kD protein to 54%, 69 kD albumin to 40%, and 77 kD protein to 49% at 10 wk in [DM + AG] compared to [DM] without changing diabetic control. It is suggested that glycation-derived late-stage protein modification is etiologically important for diabetic proteinuria, and that AG can potentially prevent diabetic HMW proteinuria.
Collapse
|
158
|
Sugo S, Matsumoto Y, Yamaoka T, Sakurabayashi I. Improved enzymatic method for determining free fatty acids in serum, with use of 3-octenoic acid. Clin Chem 1990. [DOI: 10.1093/clinchem/36.1.163] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
159
|
Sugo S, Matsumoto Y, Yamaoka T, Sakurabayashi I. Improved enzymatic method for determining free fatty acids in serum, with use of 3-octenoic acid. Clin Chem 1990; 36:163. [PMID: 2297918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
160
|
Nishimura C, Matsuura Y, Tanimoto T, Yamaoka T, Akera T, Flynn TG. cDNA cloning and expression of human aldose reductase. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1990; 284:119-27. [PMID: 1905096 DOI: 10.1007/978-1-4684-5901-2_15] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
161
|
Yamaoka T, Omote T, Adachi H, Kikuchi N, Watanabe Y, Shirosaki T. Photochemical dissociation of p-nitrobenzyl aromatic sulfonate and its application to chemical amplification resists. J PHOTOPOLYM SCI TEC 1990. [DOI: 10.2494/photopolymer.3.275] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
162
|
Watanabe Y, Kubota N, Ito Y, Yamaoka T, Miyamoto H, Komatsu S. Immunopathology of submaxillaritis in MRL/lpr mouse. THE BULLETIN OF THE KANAGAWA DENTAL COLLEGE : BKDC 1989; 17:165-9. [PMID: 2488890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
163
|
|
164
|
Omote T, Koseki K, Yamaoka T. Soluble and optically transparent fluorine-containing photoreactive polyimide precursors: Spectral sensitization by organic peroxide and organic dye combination. POLYM ENG SCI 1989. [DOI: 10.1002/pen.760291412] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
165
|
Shoji S, Imazumi K, Yamaoka T, Funakoshi T, Tanaka J, Kambara T, Ueki H, Kubota Y. Depression of prolylendopeptidase activity in the delayed hypersensitive guinea pig skin lesion induced by bovine gamma-globulin. BIOCHEMISTRY INTERNATIONAL 1989; 18:1183-92. [PMID: 2473752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Prolylendopeptidase activity was increasingly depressed with time from 6 to 24 hr after the start of sensitization in the delayed hypersensitive guinea pig skin lesion induced by bovine gamma-globulin as an antigen. The remarkably depressed activity of the enzyme in the violently inflamed skin began to be restored slowly 48 hr after sensitization, and its activity was ultimately recovered to the original level by 504 hr after a single sensitization in vivo. Depression of the enzymatic activity is caused by a novel prolyendopeptidase inhibitor, whose amino acid composition is 7 Glu, 1 Ser, 2 Gly, 1 Ala, 2 Pro, and 1 Val, generated by inflammation.
Collapse
|
166
|
Yoshikawa H, Sato M, Yamaoka T, Itakura M, Yamashita K. Proliferative effect of insulin by selective gene expression in purine metabolic pathway in primary cultured rat hepatocytes. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1989; 253B:37-42. [PMID: 2481971 DOI: 10.1007/978-1-4684-5676-9_6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
167
|
Itakura M, Yamaoka T, Yoshikawa H, Yamashita K, Sabina R, Zalkin H, Holmes E. Controllable expression of an E. coli amidophosphoribosyltransferase (ATase) gene in ATase-deficient mammalian fibroblasts--a basic model for gene therapy. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1989; 253A:531-6. [PMID: 2696349 DOI: 10.1007/978-1-4684-5673-8_86] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|
168
|
Itakura M, Yamaoka T, Yoshikawa H, Yamashita K. Paradoxical effects of glucagon on de novo purine synthesis in rat liver: in vitro phosphorylation of amidophosphoribosyltransferase. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1989; 253B:29-35. [PMID: 2481969 DOI: 10.1007/978-1-4684-5676-9_5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
169
|
Yamaoka T, Kagita F, Yoshikawa H, Itakura M, Yamashita K. Purification of rat liver amidophosphoribosyltransferase. ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 1989; 253B:21-8. [PMID: 2610116 DOI: 10.1007/978-1-4684-5676-9_4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
170
|
Shoji S, Ichikawa M, Yamaoka T, Funakoshi T, Kubota Y. High-sensitivity amino acid analysis of stained peptides and proteins from a sodium dodecyl sulphate-polyacrylamide slab gel. J Chromatogr A 1986; 354:463-70. [PMID: 3700536 DOI: 10.1016/s0021-9673(01)87050-3] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
171
|
Yamaoka T, Takada H, Yanagi Y, Kataoka T, Sakurai Y. The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice. Cancer Chemother Pharmacol 1985; 14:184-7. [PMID: 3995680 DOI: 10.1007/bf00258113] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
The antitumor effects of human lymphoblastoid interferon (HLBI) on human renal cell carcinomas transplanted in nude mice, i.e., KU-2 and RCC-1, were investigated and compared with those on other human tumors, viz. HeLa (cervical carcinoma), KB (nasopharyngeal carcinoma), H.Ep#2 (laryngeal carcinoma), and MX-1 (breast cancer). A pharmacokinetic study on HLBI was also carried out in non-tumor-bearing nude mice. HLBI therapy was performed with a dose of 10(5) IU/mouse by daily SC or IT (intratumoral) injection for 2-4 weeks. Two renal cell carcinomas, KU-2 and RCC-1, proved to be highly sensitive to HLBI. The growth of these tumors was inhibited not only by IT but also by SC injection of HLBI. In contrast, HLBI exerted only a slight effect or none at all on the other human tumors, namely, MX-1, KB, H.Ep#2, and HeLa, even when given by IT injection. The data show that the antitumor effects of HLBI depend on the types of human tumors and may be relevant to the clinical observation that renal tumors are sensitive to HLBI. The serum HLBI reached a peak level of 4,390 U/ml 1 h after a single SC injection at a dose of 10(5) IU/mouse and declined with a half-life of 4 h to 128 U/ml 24 h later. This time-course was not affected by 10 consecutive daily injections of HLBI. In nude mice, the consecutive administration of HLBI at this dose level appears to result in neither accumulation nor rapid clearance due to antibody formation. From this range of serum HLBI levels and its in vitro anticellular activity, the in vivo antitumor effects of HLBI in nude mice seemed to depend on its direct anticellular action.
Collapse
|
172
|
Naito M, Kunieda T, Nishiwaki J, Hanai S, Hara T, Yamaoka T, Sakurai K. [Case of amebic liver abscess]. RINSHO HOSHASEN. CLINICAL RADIOGRAPHY 1982; 27:1465-1468. [PMID: 7166862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
173
|
Yamaoka T, Nakamachi H, Miyata K. Studies on the characteristics of carbochromen hydrochloride crystals. II. Polymorphism and cracking in the tablets. Chem Pharm Bull (Tokyo) 1982; 30:3695-700. [PMID: 7160015 DOI: 10.1248/cpb.30.3695] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
174
|
Schaffer AM, Yamaoka T, Becker RS. Visual pigments. V. Ground and excited-state acid dissociation constants of protonated all-trans retinal schiff base and correlation with theory. Photochem Photobiol 1975; 21:297-301. [PMID: 1208656 DOI: 10.1111/j.1751-1097.1975.tb06675.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
175
|
Yogo H, Sasaki K, Yamaoka T, Kako T, Kato K. [Pre- and intra-operative care of pheochromocytoma]. HORUMON TO RINSHO. CLINICAL ENDOCRINOLOGY 1974; 22:281-5. [PMID: 4152473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
176
|
Yogo H, Sasaki T, Yamaoka T, Naruse T, Itasaka Y. Response of plasma renin activity during surgical stress. THE JAPANESE JOURNAL OF SURGERY 1973; 3:203-11. [PMID: 4802960 DOI: 10.1007/bf02468774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
177
|
Yamaoka T, Imai H, Nishida R, Mikami Y, Saito T. [A fundamental study on plaster implant applied for an infrabony pocket. I (author's transl)]. NIHON SHISHUBYO GAKKAI KAISHI 1973; 15:38-47. [PMID: 4549360 DOI: 10.2329/perio.15.38] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|
178
|
Yogo H, Sasaki T, Yamaoka T, Matsuoka K, Negoro H. A study on hormone dependency of breast cancer. NAGOYA JOURNAL OF MEDICAL SCIENCE 1971; 34:79-87. [PMID: 5113244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
179
|
Naruse T, Sasaki T, Yamaoka T, Matsuoka K, Nekita H. [Clinical application of o.p' DDD to the case of adrenal cortex cancer]. HORUMON TO RINSHO. CLINICAL ENDOCRINOLOGY 1970; 18:241-4. [PMID: 5464572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
180
|
Yamaoka T, Hosoya H, Nagakura S. Thermochemical studies on the protonation of 1,3,5-triaminobenzene. Tetrahedron 1970. [DOI: 10.1016/s0040-4020(01)93054-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
181
|
Furukawa S, Yamaoka T. Rapid corticotropin test with 1-24 peptide. NAGOYA JOURNAL OF MEDICAL SCIENCE 1968; 31:291-8. [PMID: 4304634] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
182
|
|